175 related articles for article (PubMed ID: 27240996)
1. Age-dependent increase in serum levels of indoxyl sulphate and p-cresol sulphate is not related to their precursors: Tryptophan and tyrosine.
Wyczalkowska-Tomasik A; Czarkowska-Paczek B; Giebultowicz J; Wroczynski P; Paczek L
Geriatr Gerontol Int; 2017 Jun; 17(6):1022-1026. PubMed ID: 27240996
[TBL] [Abstract][Full Text] [Related]
2. Serum total p-cresol and indoxyl sulfate correlated with stage of chronic kidney disease in renal transplant recipients.
Huang ST; Shu KH; Cheng CH; Wu MJ; Yu TM; Chuang YW; Chen CH
Transplant Proc; 2012 Apr; 44(3):621-4. PubMed ID: 22483453
[TBL] [Abstract][Full Text] [Related]
3. Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.
Shafi T; Sirich TL; Meyer TW; Hostetter TH; Plummer NS; Hwang S; Melamed ML; Banerjee T; Coresh J; Powe NR
Kidney Int; 2017 Dec; 92(6):1484-1492. PubMed ID: 28739139
[TBL] [Abstract][Full Text] [Related]
4. Reference ranges and biological variation of free and total serum indoxyl- and p-cresyl sulphate measured with a rapid UPLC fluorescence detection method.
Pretorius CJ; McWhinney BC; Sipinkoski B; Johnson LA; Rossi M; Campbell KL; Ungerer JP
Clin Chim Acta; 2013 Apr; 419():122-6. PubMed ID: 23428591
[TBL] [Abstract][Full Text] [Related]
5. Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury.
Veldeman L; Vanmassenhove J; Van Biesen W; Massy ZA; Liabeuf S; Glorieux G; Vanholder R
Int Urol Nephrol; 2019 Feb; 51(2):293-302. PubMed ID: 30604232
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with blood concentrations of indoxyl sulfate and p-cresol in patients undergoing peritoneal dialysis.
Lee CT; Kuo CC; Chen YM; Hsu CY; Lee WC; Tsai YC; Ng HY; Kuo LC; Chiou TT; Yang YK; Cheng BC; Chen JB
Perit Dial Int; 2010; 30(4):456-63. PubMed ID: 20338972
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
[TBL] [Abstract][Full Text] [Related]
8. Higher cerebrospinal fluid to plasma ratio of p-cresol sulfate and indoxyl sulfate in patients with Parkinson's disease.
Sankowski B; Księżarczyk K; Raćkowska E; Szlufik S; Koziorowski D; Giebułtowicz J
Clin Chim Acta; 2020 Feb; 501():165-173. PubMed ID: 31726035
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a LC-MS/MS method for quantitative analysis of uraemic toxins p-cresol sulphate and indoxyl sulphate in saliva.
Giebułtowicz J; Korytowska N; Sankowski B; Wroczyński P
Talanta; 2016 Apr; 150():593-8. PubMed ID: 26838447
[TBL] [Abstract][Full Text] [Related]
10. Removal of protein-bound uraemic toxins by haemodialysis.
Niwa T
Blood Purif; 2013; 35 Suppl 2():20-5. PubMed ID: 23676831
[TBL] [Abstract][Full Text] [Related]
11. Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis.
Chen X; Gao S; Ruan M; Chen S; Xu J; Xing X; Pan X; Mei C; Mao Z
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29921575
[TBL] [Abstract][Full Text] [Related]
12. LC-MS/MS method for simultaneous determination of serum p-cresyl sulfate and indoxyl sulfate in patients undergoing peritoneal dialysis.
Shu C; Chen X; Xia T; Zhang F; Gao S; Chen W
Biomed Chromatogr; 2016 Nov; 30(11):1782-1788. PubMed ID: 27129599
[TBL] [Abstract][Full Text] [Related]
13. Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients.
Sirich TL; Plummer NS; Gardner CD; Hostetter TH; Meyer TW
Clin J Am Soc Nephrol; 2014 Sep; 9(9):1603-10. PubMed ID: 25147155
[TBL] [Abstract][Full Text] [Related]
14. Effects of AST-120 on blood concentrations of protein-bound uremic toxins and biomarkers of cardiovascular risk in chronic dialysis patients.
Lee CT; Hsu CY; Tain YL; Ng HY; Cheng BC; Yang CC; Wu CH; Chiou TT; Lee YT; Liao SC
Blood Purif; 2014; 37(1):76-83. PubMed ID: 24576840
[TBL] [Abstract][Full Text] [Related]
15. Increased p-cresyl sulfate level is independently associated with poor outcomes in patients with heart failure.
Wang CH; Cheng ML; Liu MH; Shiao MS; Hsu KH; Huang YY; Lin CC; Lin JF
Heart Vessels; 2016 Jul; 31(7):1100-8. PubMed ID: 26135926
[TBL] [Abstract][Full Text] [Related]
16. p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.
Meijers BK; De Loor H; Bammens B; Verbeke K; Vanrenterghem Y; Evenepoel P
Clin J Am Soc Nephrol; 2009 Dec; 4(12):1932-8. PubMed ID: 19833905
[TBL] [Abstract][Full Text] [Related]
17. Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study.
Rossi M; Campbell K; Johnson D; Stanton T; Pascoe E; Hawley C; Dimeski G; McWhinney B; Ungerer J; Isbel N
Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):1035-42. PubMed ID: 24880738
[TBL] [Abstract][Full Text] [Related]
18. Effect of a sustained difference in hemodialytic clearance on the plasma levels of p-cresol sulfate and indoxyl sulfate.
Camacho O; Rosales MC; Shafi T; Fullman J; Plummer NS; Meyer TW; Sirich TL
Nephrol Dial Transplant; 2016 Aug; 31(8):1335-41. PubMed ID: 27190347
[TBL] [Abstract][Full Text] [Related]
19. Serum protein-bound uraemic toxins and clinical outcomes in haemodialysis patients.
Lin CJ; Wu CJ; Pan CF; Chen YC; Sun FJ; Chen HH
Nephrol Dial Transplant; 2010 Nov; 25(11):3693-700. PubMed ID: 20466687
[TBL] [Abstract][Full Text] [Related]
20. p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.
Wu IW; Hsu KH; Lee CC; Sun CY; Hsu HJ; Tsai CJ; Tzen CY; Wang YC; Lin CY; Wu MS
Nephrol Dial Transplant; 2011 Mar; 26(3):938-47. PubMed ID: 20884620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]